Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?

Int J Cardiol. 2018 Apr 1:256:39. doi: 10.1016/j.ijcard.2017.10.113.

Authors

Biao Li¹, Chao Sun¹, Fen Qin¹, Na Liu¹, Zhihong Wu², Qiming Liu¹

Affiliations

¹ Department of Cardiology/Cardiac Catheterisation Lab, Second Xiangya Hospital, Central South University, Changsha City, Hunan Province 410011, China.
² Department of Cardiology/Cardiac Catheterisation Lab, Second Xiangya Hospital, Central South University, Changsha City, Hunan Province 410011, China. Electronic address: [email protected].

PMID: 29454418
DOI: 10.1016/j.ijcard.2017.10.113

No abstract available

Keywords: Atrial fibrillation; Direct oral anticoagulants; Hypertrophic cardiomyopathy; Vitamin K antagonists.

Publication types

Letter
Comment

MeSH terms

Administration, Oral
Anticoagulants*
Atrial Fibrillation*
Cardiomyopathy, Hypertrophic
Humans
Stroke
Vitamin K
Warfarin

Substances

Anticoagulants
Vitamin K
Warfarin